Clinical use of stem cells in orthopaedics part 14

Stem cell 2

 

 

Studies to date show the safety of using autologous  human mesenchymal stem cells for bone regeneration in segmental long-bone defects. None of the reports mention adverse effects, such as inflammation or excessive tissue growth. In view of the report that extensively cultured mesenchymal stem cells (4-5 months) can develop genomic instability, an indicator of malignant transformation, the relatively short in vitro expansion period (6-8 weeks) may account for the lack of reported malignancy in the clinical studies performed so far.

Advertisements

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s